FIELD: medicine, pharmaceutics.
SUBSTANCE: present group of inventions refers to medicine, namely to therapy, and concerns treating vegetovascular dystonia (VVD). That is ensured by administering a pharmaceutical composition containing activated potentiated angiotensin II receptor antibodies and activated potentiated endothelial NO-synthase antibodies.
EFFECT: method provides effective treatment of vegetovascular dystonia ensured by the synergetic action of the ingredients of the pharmaceutical composition.
1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING CHRONIC CARDIAC FAILURE AND PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC CARDIAC FAILURE | 2011 |
|
RU2523451C2 |
| METHOD OF TREATMENT AND PREVENTION OF ARTERIAL HYPERTENSION AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ARTERIAL HYPERTENSION | 2010 |
|
RU2525156C2 |
| METHOD OF TREATING CHRONIC HEART FAILURE AND PHARMACEUTICAL COMPOSITION FOR COMPLEX THERAPY OF CHRONIC HEART FAILURE | 2010 |
|
RU2525155C2 |
| METHOD FOR INCREASE OF PHARMACOLOGICAL ACTIVITY OF ACTIVE AGENT OF DRUG PREPARATION AND PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2526153C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2527689C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543331C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543332C2 |
| THERAPEUTIC AGENT AND METHOD OF TREATING VEGETATIVE-VASCULAR DYSTONIA, DIZZINESS SYNDROME OF VARIOUS ORIGINS, AND KINETOSIS | 2010 |
|
RU2542453C2 |
| DRUG FOR REDUCING INSULIN RESISTANCE AND FOR TREATING DIABETES, METHOD OF REDUCING INSULIN RESISTANCE, METHOD OF TREATING DIABETES AND METHOD OF TREATING DIABETES WITH INSULIN AND/OR HYPOGLYCEMIC PREPARATIONS | 2011 |
|
RU2509572C2 |
| MEDICATION BASED ON SUBSTANCE INFLUENCING ENDOCANNABINOID SYSTEM | 2013 |
|
RU2568896C2 |
